C07C 317/32
With sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic
Official title: with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
C07C317/32 (With sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic) appears on 781 US grants and 763 published applications in this corpus.
Search patents in C07C- Granted patents
- 781
- Published applications
- 763
- Assignees
- 442
- Inventors
- 2,621
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 6 | 0 |
| 1989 | 4 | 0 |
| 1990 | 10 | 0 |
| 1991 | 12 | 0 |
| 1992 | 17 | 0 |
| 1993 | 16 | 0 |
| 1994 | 18 | 0 |
| 1995 | 16 | 0 |
| 1996 | 18 | 0 |
| 1997 | 19 | 0 |
| 1998 | 20 | 0 |
| 1999 | 23 | 0 |
| 2000 | 11 | 0 |
| 2001 | 16 | 5 |
| 2002 | 27 | 35 |
| 2003 | 21 | 45 |
| 2004 | 34 | 52 |
| 2005 | 24 | 40 |
| 2006 | 20 | 43 |
| 2007 | 21 | 30 |
| 2008 | 22 | 30 |
| 2009 | 21 | 34 |
| 2010 | 30 | 31 |
| 2011 | 25 | 25 |
| 2012 | 23 | 20 |
| 2013 | 21 | 29 |
| 2014 | 29 | 38 |
| 2015 | 23 | 33 |
| 2016 | 26 | 35 |
| 2017 | 27 | 29 |
| 2018 | 29 | 37 |
| 2019 | 25 | 21 |
| 2020 | 17 | 25 |
| 2021 | 15 | 13 |
| 2022 | 14 | 25 |
| 2023 | 13 | 23 |
| 2024 | 23 | 35 |
| 2025 | 14 | 25 |
| 2026 | 8 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 2830 Jun 2026US 12,668,571 B2Dana-Farber Cancer Institute, Inc.
- Substituted phenyl sulfide compound and application thereof16 Jun 2026US 12,655,099 B2Jiangsu Yangnong Chemical Co., Ltd.
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Antibacterial compounds2 Jun 2026US 12,643,875 B2The Penn State Research Foundation
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Antibacterial compounds17 Sep 2026US 2026/0274816 A1The Penn State Research Foundation
- Chalcone-based chemotherapeutic compounds and treatments for cancer23 Jul 2026US 2026/0209209 A1Qatar University
- Dual inhibitors for hdac3 and hiv-1 pr15 Jan 2026US 2026/0014174 A1Purdue Research Foundation
Most cited
By later US patents
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007
- Tetraaryl benzidines128US 5,639,914 AHodogaya Chemical Co., Ltd. · 1997
- Amine compound and electro-luminescence device comprising same122US 5,707,747 AHodogaya Chemical Co., Ltd. · 1998
- Aryloxypropanolamine .beta. 3 adrenergic agonists115US 5,541,204 ABristol-Myers Squibb Company · 1996